{"entity":{"type":"insider","cik":"0001299430","url":"/insider/0001299430","json_url":"/insider/0001299430.json","name":"Alafi Christopher D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":113,"n_filings":40,"first":"2005-12-06","last":"2021-05-28","span_basis":"filed_date"},"name_variants":[{"name":"Alafi Christopher D","source":"filing","n_filings":40,"first_seen":"2005-12-06","last_seen":"2021-05-28"}],"transactions":[{"id":4785447,"accession":"0001209191-21-036624","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-036624","line_url":"/filing/0001209191-21-036624#line-2","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38843.0,"shares_display":"38,843","price_per_share":40.12,"price_display":"40.12","price_state":"stated","total_value":1558381.16,"total_display":"1,558,381.16","total_whole":"1,558,381","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-05-28","scope":"insider"},{"id":4785443,"accession":"0001209191-21-036624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-036624","line_url":"/filing/0001209191-21-036624#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8482.0,"shares_display":"8,482","price_per_share":40.01,"price_display":"40.01","price_state":"stated","total_value":339364.82,"total_display":"339,364.82","total_whole":"339,365","shares_owned_after":133843.0,"shares_owned_after_display":"133,843","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-05-28","scope":"insider"},{"id":5333623,"accession":"0001209191-21-035750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-035750","line_url":"/filing/0001209191-21-035750#line-2","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26575.0,"shares_display":"26,575","price_per_share":40.47,"price_display":"40.47","price_state":"stated","total_value":1075490.25,"total_display":"1,075,490.25","total_whole":"1,075,490","shares_owned_after":142325.0,"shares_owned_after_display":"142,325","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-25","scope":"insider"},{"id":5333616,"accession":"0001209191-21-035750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035750","line_url":"/filing/0001209191-21-035750#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":44000.0,"total_display":"44,000.00","total_whole":"44,000","shares_owned_after":168900.0,"shares_owned_after_display":"168,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-25","scope":"insider"},{"id":3018174,"accession":"0001209191-20-050301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-050301","line_url":"/filing/0001209191-20-050301#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49500.0,"shares_display":"49,500","price_per_share":29.6,"price_display":"29.60","price_state":"stated","total_value":1465200.0,"total_display":"1,465,200.00","total_whole":"1,465,200","shares_owned_after":4743770.0,"shares_owned_after_display":"4,743,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-14","scope":"insider"},{"id":3046809,"accession":"0001209191-20-050141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-050141","line_url":"/filing/0001209191-20-050141#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21000.0,"shares_display":"21,000","price_per_share":28.08,"price_display":"28.08","price_state":"stated","total_value":589680.0,"total_display":"589,680.00","total_whole":"589,680","shares_owned_after":4694270.0,"shares_owned_after_display":"4,694,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-11","scope":"insider"},{"id":8010321,"accession":"0001209191-19-049172","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-049172","line_url":"/filing/0001209191-19-049172","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":485000.0,"shares_display":"485,000","price_per_share":10.257067134020618,"price_display":"10.26","price_state":"stated","total_value":4974677.56,"total_display":"4,974,677.56","total_whole":"4,974,678","shares_owned_after":4667030.0,"shares_owned_after_display":"4,667,030","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-11","scope":"insider","n_lines":4},{"id":8454359,"accession":"0001209191-19-048307","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-048307","line_url":"/filing/0001209191-19-048307#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":8.5217,"price_display":"8.52","price_state":"stated","total_value":1065212.5,"total_display":"1,065,212.50","total_whole":"1,065,213","shares_owned_after":4188270.0,"shares_owned_after_display":"4,188,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-30","filed_date":"2019-09-04","scope":"insider"},{"id":7979143,"accession":"0001209191-19-037205","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-037205","line_url":"/filing/0001209191-19-037205","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":170000.0,"shares_display":"170,000","price_per_share":11.728193882352942,"price_display":"11.73","price_state":"stated","total_value":1993792.96,"total_display":"1,993,792.96","total_whole":"1,993,793","shares_owned_after":111295.0,"shares_owned_after_display":"111,295","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-12","filed_date":"2019-06-14","scope":"insider","n_lines":3},{"id":8316402,"accession":"0001209191-19-030123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-030123","line_url":"/filing/0001209191-19-030123#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":12.5635,"price_display":"12.56","price_state":"stated","total_value":1256350.0,"total_display":"1,256,350.00","total_whole":"1,256,350","shares_owned_after":4053270.0,"shares_owned_after_display":"4,053,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-15","scope":"insider"},{"id":6041569,"accession":"0001209191-18-000889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-000889","line_url":"/filing/0001209191-18-000889#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1001.0,"shares_display":"1,001","price_per_share":14.48,"price_display":"14.48","price_state":"stated","total_value":14494.48,"total_display":"14,494.48","total_whole":"14,494","shares_owned_after":745467.0,"shares_owned_after_display":"745,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2018-01-03","scope":"insider"},{"id":9270921,"accession":"0001209191-19-038093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-038093","line_url":"/filing/0001209191-19-038093#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":15.55,"price_display":"15.55","price_state":"stated","total_value":155500.0,"total_display":"155,500.00","total_whole":"155,500","shares_owned_after":3963270.0,"shares_owned_after_display":"3,963,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2019-06-19","scope":"insider"},{"id":4662168,"accession":"0001209191-17-062570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-062570","line_url":"/filing/0001209191-17-062570#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":15.55,"price_display":"15.55","price_state":"stated","total_value":155500.0,"total_display":"155,500.00","total_whole":"155,500","shares_owned_after":744466.0,"shares_owned_after_display":"744,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2017-11-27","scope":"insider"},{"id":4907368,"accession":"0001209191-17-055365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-055365","line_url":"/filing/0001209191-17-055365#line-2","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":258065.0,"shares_display":"258,065","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":4000007.5,"total_display":"4,000,007.50","total_whole":"4,000,008","shares_owned_after":3953270.0,"shares_owned_after_display":"3,953,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-03","scope":"insider"},{"id":2747519,"accession":"0001209191-16-153903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-153903","line_url":"/filing/0001209191-16-153903#line-2","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20826.0,"shares_display":"20,826","price_per_share":16.1355,"price_display":"16.14","price_state":"stated","total_value":336037.923,"total_display":"336,037.92","total_whole":"336,038","shares_owned_after":3695205.0,"shares_owned_after_display":"3,695,205","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-07","filed_date":"2016-12-07","scope":"insider"},{"id":2747494,"accession":"0001209191-16-153903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153903","line_url":"/filing/0001209191-16-153903#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44174.0,"shares_display":"44,174","price_per_share":16.3319,"price_display":"16.33","price_state":"stated","total_value":721445.3506,"total_display":"721,445.35","total_whole":"721,445","shares_owned_after":3674379.0,"shares_owned_after_display":"3,674,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-06","filed_date":"2016-12-07","scope":"insider"},{"id":3185202,"accession":"0001209191-16-150876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-150876","line_url":"/filing/0001209191-16-150876#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34000.0,"shares_display":"34,000","price_per_share":14.4991,"price_display":"14.50","price_state":"stated","total_value":492969.4,"total_display":"492,969.40","total_whole":"492,969","shares_owned_after":3630205.0,"shares_owned_after_display":"3,630,205","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-17","scope":"insider"},{"id":2696752,"accession":"0001209191-16-103479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-103479","line_url":"/filing/0001209191-16-103479#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":29.703,"price_display":"29.70","price_state":"stated","total_value":2970300.0,"total_display":"2,970,300.00","total_whole":"2,970,300","shares_owned_after":728828.0,"shares_owned_after_display":"728,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-02-29","scope":"insider"},{"id":8454581,"accession":"0001181431-15-004544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-15-004544","line_url":"/filing/0001181431-15-004544#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":627604.0,"shares_owned_after_display":"627,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-12","scope":"insider"},{"id":6463339,"accession":"0001181431-14-037802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037802","line_url":"/filing/0001181431-14-037802#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1422.0,"shares_display":"1,422","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":20974.5,"total_display":"20,974.50","total_whole":"20,975","shares_owned_after":3596205.0,"shares_owned_after_display":"3,596,205","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":6343278,"accession":"0001181431-14-037471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037471","line_url":"/filing/0001181431-14-037471#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":516250.0,"total_display":"516,250.00","total_whole":"516,250","shares_owned_after":3594783.0,"shares_owned_after_display":"3,594,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-11-28","scope":"insider"},{"id":6463281,"accession":"0001181431-14-037064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-037064","line_url":"/filing/0001181431-14-037064#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1034.0,"shares_display":"1,034","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":14734.5,"total_display":"14,734.50","total_whole":"14,735","shares_owned_after":3559783.0,"shares_owned_after_display":"3,559,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-19","filed_date":"2014-11-21","scope":"insider"},{"id":6554087,"accession":"0001181431-14-036724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-036724","line_url":"/filing/0001181431-14-036724#line-2","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3531.0,"shares_display":"3,531","price_per_share":14.23,"price_display":"14.23","price_state":"stated","total_value":50246.13,"total_display":"50,246.13","total_whole":"50,246","shares_owned_after":3558749.0,"shares_owned_after_display":"3,558,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-18","scope":"insider"},{"id":6554086,"accession":"0001181431-14-036724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-036724","line_url":"/filing/0001181431-14-036724#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133.0,"shares_display":"133","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":2004.31,"total_display":"2,004.31","total_whole":"2,004","shares_owned_after":3555218.0,"shares_owned_after_display":"3,555,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-18","scope":"insider"},{"id":6786684,"accession":"0001181431-14-036339","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-036339","line_url":"/filing/0001181431-14-036339#line-3","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":15.12,"price_display":"15.12","price_state":"stated","total_value":33264.0,"total_display":"33,264.00","total_whole":"33,264","shares_owned_after":3555085.0,"shares_owned_after_display":"3,555,085","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-13","scope":"insider"},{"id":6786679,"accession":"0001181431-14-036339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-036339","line_url":"/filing/0001181431-14-036339#line-2","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":15.23,"price_display":"15.23","price_state":"stated","total_value":76150.0,"total_display":"76,150.00","total_whole":"76,150","shares_owned_after":3552885.0,"shares_owned_after_display":"3,552,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-13","scope":"insider"},{"id":6786676,"accession":"0001181431-14-036339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-036339","line_url":"/filing/0001181431-14-036339#line-1","is_derivative":false,"issuer_cik":"0001299430","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001299430","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":15.55,"price_display":"15.55","price_state":"stated","total_value":77750.0,"total_display":"77,750.00","total_whole":"77,750","shares_owned_after":3547885.0,"shares_owned_after_display":"3,547,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-13","scope":"insider"},{"id":5159663,"accession":"0001144204-13-047162","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-13-047162","line_url":"/filing/0001144204-13-047162#line-3","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22220.0,"shares_display":"22,220","price_per_share":3.7,"price_display":"3.70","price_state":"stated","total_value":82214.0,"total_display":"82,214.00","total_whole":"82,214","shares_owned_after":1266628.0,"shares_owned_after_display":"1,266,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-20","filed_date":"2013-08-20","scope":"insider"},{"id":5159659,"accession":"0001144204-13-047162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-047162","line_url":"/filing/0001144204-13-047162#line-2","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239021.0,"shares_display":"239,021","price_per_share":3.743,"price_display":"3.74","price_state":"stated","total_value":894655.603,"total_display":"894,655.60","total_whole":"894,656","shares_owned_after":1288848.0,"shares_owned_after_display":"1,288,848","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-19","filed_date":"2013-08-20","scope":"insider"},{"id":3198900,"accession":"0001289340-12-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001289340-12-000040","line_url":"/filing/0001289340-12-000040#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8674908.0,"shares_display":"8,674,908","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":12666281.0,"shares_owned_after_display":"12,666,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-10","filed_date":"2012-05-14","scope":"insider"},{"id":9017595,"accession":"0001289340-11-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001289340-11-000051","line_url":"/filing/0001289340-11-000051#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64468.0,"shares_display":"64,468","price_per_share":1.34,"price_display":"1.34","price_state":"stated","total_value":86387.12,"total_display":"86,387.12","total_whole":"86,387","shares_owned_after":3991373.0,"shares_owned_after_display":"3,991,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-12","filed_date":"2011-09-13","scope":"insider"},{"id":8950578,"accession":"0001289340-11-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001289340-11-000049","line_url":"/filing/0001289340-11-000049#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35532.0,"shares_display":"35,532","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":47257.56,"total_display":"47,257.56","total_whole":"47,258","shares_owned_after":3926905.0,"shares_owned_after_display":"3,926,905","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-09","filed_date":"2011-09-12","scope":"insider"},{"id":8870030,"accession":"0001289340-11-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001289340-11-000028","line_url":"/filing/0001289340-11-000028#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":167500.0,"total_display":"167,500.00","total_whole":"167,500","shares_owned_after":126000.0,"shares_owned_after_display":"126,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-03","filed_date":"2011-06-06","scope":"insider"},{"id":7623992,"accession":"0000950138-10-000534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-10-000534","line_url":"/filing/0000950138-10-000534#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":3.2499,"price_display":"3.25","price_state":"stated","total_value":84497.4,"total_display":"84,497.40","total_whole":"84,497","shares_owned_after":76000.0,"shares_owned_after_display":"76,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-18","filed_date":"2010-08-19","scope":"insider"},{"id":7541623,"accession":"0000950138-10-000154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950138-10-000154","line_url":"/filing/0000950138-10-000154#line-2","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30200.0,"shares_display":"30,200","price_per_share":4.8249,"price_display":"4.82","price_state":"stated","total_value":145711.98,"total_display":"145,711.98","total_whole":"145,712","shares_owned_after":225136.0,"shares_owned_after_display":"225,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-03","filed_date":"2010-03-04","scope":"insider"},{"id":7541621,"accession":"0000950138-10-000154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-10-000154","line_url":"/filing/0000950138-10-000154#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19800.0,"shares_display":"19,800","price_per_share":4.8289,"price_display":"4.83","price_state":"stated","total_value":95612.22,"total_display":"95,612.22","total_whole":"95,612","shares_owned_after":194936.0,"shares_owned_after_display":"194,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-02","filed_date":"2010-03-04","scope":"insider"},{"id":5632149,"accession":"0000950138-09-000574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-09-000574","line_url":"/filing/0000950138-09-000574#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":3.4907,"price_display":"3.49","price_state":"stated","total_value":104721.0,"total_display":"104,721.00","total_whole":"104,721","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-08-26","filed_date":"2009-08-28","scope":"insider"},{"id":5870030,"accession":"0000950138-09-000373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950138-09-000373","line_url":"/filing/0000950138-09-000373","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.449866666666667,"price_display":"3.45","price_state":"stated","total_value":51748.0,"total_display":"51,748.00","total_whole":"51,748","shares_owned_after":3891273.0,"shares_owned_after_display":"3,891,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-05-29","filed_date":"2009-06-02","scope":"insider","n_lines":2},{"id":5714669,"accession":"0000950138-09-000359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950138-09-000359","line_url":"/filing/0000950138-09-000359#line-2","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8537.0,"shares_display":"8,537","price_per_share":3.4721,"price_display":"3.47","price_state":"stated","total_value":29641.3177,"total_display":"29,641.32","total_whole":"29,641","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-05-14","filed_date":"2009-05-15","scope":"insider"},{"id":5714668,"accession":"0000950138-09-000359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-09-000359","line_url":"/filing/0000950138-09-000359#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41463.0,"shares_display":"41,463","price_per_share":3.4872,"price_display":"3.49","price_state":"stated","total_value":144589.7736,"total_display":"144,589.77","total_whole":"144,590","shares_owned_after":41463.0,"shares_owned_after_display":"41,463","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-05-13","filed_date":"2009-05-15","scope":"insider"},{"id":3438059,"accession":"0000950138-08-000978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-08-000978","line_url":"/filing/0000950138-08-000978#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1012130.0,"shares_display":"1,012,130","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":4696283.2,"total_display":"4,696,283.20","total_whole":"4,696,283","shares_owned_after":3880373.0,"shares_owned_after_display":"3,880,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-29","filed_date":"2008-12-31","scope":"insider"},{"id":3528382,"accession":"0000950138-08-000867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-08-000867","line_url":"/filing/0000950138-08-000867#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.5252,"price_display":"3.53","price_state":"stated","total_value":35252.0,"total_display":"35,252.00","total_whole":"35,252","shares_owned_after":2868243.0,"shares_owned_after_display":"2,868,243","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-20","filed_date":"2008-11-21","scope":"insider"},{"id":2554753,"accession":"0000950138-08-000852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950138-08-000852","line_url":"/filing/0000950138-08-000852#line-2","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44075.0,"shares_display":"44,075","price_per_share":3.5569,"price_display":"3.56","price_state":"stated","total_value":156770.3675,"total_display":"156,770.37","total_whole":"156,770","shares_owned_after":2858243.0,"shares_owned_after_display":"2,858,243","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-18","filed_date":"2008-11-18","scope":"insider"},{"id":2554749,"accession":"0000950138-08-000852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-08-000852","line_url":"/filing/0000950138-08-000852#line-1","is_derivative":false,"issuer_cik":"0001289340","issuer_name":"Stereotaxis, Inc.","issuer_ticker":"STXS","issuer_name_source":null,"issuer_url":"/issuer/0001289340","owner_cik":"0001299430","owner_name":"Alafi Christopher D","owner_display_name":"Alafi Christopher D","owner_url":"/insider/0001299430","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22338.0,"shares_display":"22,338","price_per_share":2.6495,"price_display":"2.65","price_state":"stated","total_value":59184.531,"total_display":"59,184.53","total_whole":"59,185","shares_owned_after":2814168.0,"shares_owned_after_display":"2,814,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-17","filed_date":"2008-11-18","scope":"insider"}],"collapsed":true,"next_cursor":"2008-11-17|2554749","ledger_fault":false,"count":{"value":113,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":107,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":113},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001567514","name":"Intra-Cellular Therapies, Inc.","url":"/issuer/0001567514","role":"Director, Ten percent owner","n_filings":21,"first_seen":"2014-11-13","last_seen":"2021-05-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001289340","name":"Stereotaxis, Inc.","url":"/issuer/0001289340","role":"Director, Ten percent owner","n_filings":19,"first_seen":"2005-12-06","last_seen":"2013-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001299430","retrieved_at":"2026-08-27T06:48:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}